Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Sell
1
DMYY Quote, Financials, Valuation and Earnings
Last price:
$12.70
Seasonality move
:
-0.18%
Day range:
$12.24 - $12.96
52-week range:
$10.40 - $15.53
Dividend yield:
0%
P/E ratio:
59.33x
P/S ratio:
--
P/B ratio:
3.42x
Volume:
11.6K
Avg. volume:
51.4K
1-year change:
14.74%
Market cap:
$48.2M
Revenue:
--
EPS (TTM):
-$1.32
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
DMYY
dMY Squared Technology Group
|
-- | -- | -- | -- | -- |
|
CCAP
Crescent Capital BDC
|
$42.5M | $0.47 | 85.64% | -14.91% | $17.33 |
|
FHLT
Future Health ESG
|
-- | -- | -- | -- | -- |
|
GMFI
Aetherium Acquisition
|
-- | -- | -- | -- | -- |
|
GRAF
Graf Global
|
-- | -- | -- | -- | -- |
|
LEGT
Legato Merger Corp III
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
DMYY
dMY Squared Technology Group
|
$12.30 | -- | $48.2M | 59.33x | $0.00 | 0% | -- |
|
CCAP
Crescent Capital BDC
|
$14.58 | $17.33 | $540.4M | 10.90x | $0.42 | 12.62% | 8.95x |
|
FHLT
Future Health ESG
|
$10.96 | -- | $65.1M | -- | $0.00 | 0% | -- |
|
GMFI
Aetherium Acquisition
|
$11.04 | -- | $56.4M | 367.67x | $0.00 | 0% | -- |
|
GRAF
Graf Global
|
$10.47 | -- | $301M | 39.46x | $0.00 | 0% | -- |
|
LEGT
Legato Merger Corp III
|
$10.71 | -- | $276.3M | 29.75x | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
DMYY
dMY Squared Technology Group
|
-- | -0.068 | -- | -- |
|
CCAP
Crescent Capital BDC
|
55.39% | 0.392 | 142.31% | 0.62x |
|
FHLT
Future Health ESG
|
-- | 0.000 | -- | -- |
|
GMFI
Aetherium Acquisition
|
-- | 0.000 | -- | -- |
|
GRAF
Graf Global
|
-- | 0.000 | -- | -- |
|
LEGT
Legato Merger Corp III
|
-- | -0.025 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
DMYY
dMY Squared Technology Group
|
-- | -$492.2K | -- | -- | -- | -$773.6K |
|
CCAP
Crescent Capital BDC
|
-- | -- | 3.07% | 6.66% | 254.33% | -$15.1M |
|
FHLT
Future Health ESG
|
-- | -- | -- | -- | -- | -- |
|
GMFI
Aetherium Acquisition
|
-- | -$120.3K | -- | -- | -- | -$480.1K |
|
GRAF
Graf Global
|
-- | -$273.2K | -- | -- | -- | -$119.5K |
|
LEGT
Legato Merger Corp III
|
-- | -$167.1K | -- | -- | -- | -$86.2K |
dMY Squared Technology Group vs. Competitors
-
Which has Higher Returns DMYY or CCAP?
Crescent Capital BDC has a net margin of -- compared to dMY Squared Technology Group's net margin of 54.76%. dMY Squared Technology Group's return on equity of -- beat Crescent Capital BDC's return on equity of 6.66%.
Company Gross Margin Earnings Per Share Invested Capital DMYYdMY Squared Technology Group-- -$1.16 -- CCAPCrescent Capital BDC-- $0.11 $1.6B -
What do Analysts Say About DMYY or CCAP?
dMY Squared Technology Group has a consensus price target of --, signalling downside risk potential of --. On the other hand Crescent Capital BDC has an analysts' consensus of $17.33 which suggests that it could grow by 18.88%. Given that Crescent Capital BDC has higher upside potential than dMY Squared Technology Group, analysts believe Crescent Capital BDC is more attractive than dMY Squared Technology Group.
Company Buy Ratings Hold Ratings Sell Ratings DMYYdMY Squared Technology Group0 0 0 CCAPCrescent Capital BDC3 2 0 -
Is DMYY or CCAP More Risky?
dMY Squared Technology Group has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Crescent Capital BDC has a beta of 0.522, suggesting its less volatile than the S&P 500 by 47.848%.
-
Which is a Better Dividend Stock DMYY or CCAP?
dMY Squared Technology Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Crescent Capital BDC offers a yield of 12.62% to investors and pays a quarterly dividend of $0.42 per share. dMY Squared Technology Group pays -- of its earnings as a dividend. Crescent Capital BDC pays out 102.15% of its earnings as a dividend.
-
Which has Better Financial Ratios DMYY or CCAP?
dMY Squared Technology Group quarterly revenues are --, which are smaller than Crescent Capital BDC quarterly revenues of $7.1M. dMY Squared Technology Group's net income of -$4.6M is lower than Crescent Capital BDC's net income of $3.9M. Notably, dMY Squared Technology Group's price-to-earnings ratio is 59.33x while Crescent Capital BDC's PE ratio is 10.90x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for dMY Squared Technology Group is -- versus 8.95x for Crescent Capital BDC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DMYYdMY Squared Technology Group-- 59.33x -- -$4.6M CCAPCrescent Capital BDC8.95x 10.90x $7.1M $3.9M
-
Which has Higher Returns DMYY or FHLT?
Future Health ESG has a net margin of -- compared to dMY Squared Technology Group's net margin of --. dMY Squared Technology Group's return on equity of -- beat Future Health ESG's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital DMYYdMY Squared Technology Group-- -$1.16 -- FHLTFuture Health ESG-- -- -- -
What do Analysts Say About DMYY or FHLT?
dMY Squared Technology Group has a consensus price target of --, signalling downside risk potential of --. On the other hand Future Health ESG has an analysts' consensus of -- which suggests that it could fall by --. Given that dMY Squared Technology Group has higher upside potential than Future Health ESG, analysts believe dMY Squared Technology Group is more attractive than Future Health ESG.
Company Buy Ratings Hold Ratings Sell Ratings DMYYdMY Squared Technology Group0 0 0 FHLTFuture Health ESG0 0 0 -
Is DMYY or FHLT More Risky?
dMY Squared Technology Group has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Future Health ESG has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock DMYY or FHLT?
dMY Squared Technology Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Future Health ESG offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. dMY Squared Technology Group pays -- of its earnings as a dividend. Future Health ESG pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios DMYY or FHLT?
dMY Squared Technology Group quarterly revenues are --, which are smaller than Future Health ESG quarterly revenues of --. dMY Squared Technology Group's net income of -$4.6M is higher than Future Health ESG's net income of --. Notably, dMY Squared Technology Group's price-to-earnings ratio is 59.33x while Future Health ESG's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for dMY Squared Technology Group is -- versus -- for Future Health ESG. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DMYYdMY Squared Technology Group-- 59.33x -- -$4.6M FHLTFuture Health ESG-- -- -- --
-
Which has Higher Returns DMYY or GMFI?
Aetherium Acquisition has a net margin of -- compared to dMY Squared Technology Group's net margin of --. dMY Squared Technology Group's return on equity of -- beat Aetherium Acquisition's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital DMYYdMY Squared Technology Group-- -$1.16 -- GMFIAetherium Acquisition-- $0.02 -- -
What do Analysts Say About DMYY or GMFI?
dMY Squared Technology Group has a consensus price target of --, signalling downside risk potential of --. On the other hand Aetherium Acquisition has an analysts' consensus of -- which suggests that it could fall by --. Given that dMY Squared Technology Group has higher upside potential than Aetherium Acquisition, analysts believe dMY Squared Technology Group is more attractive than Aetherium Acquisition.
Company Buy Ratings Hold Ratings Sell Ratings DMYYdMY Squared Technology Group0 0 0 GMFIAetherium Acquisition0 0 0 -
Is DMYY or GMFI More Risky?
dMY Squared Technology Group has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Aetherium Acquisition has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock DMYY or GMFI?
dMY Squared Technology Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Aetherium Acquisition offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. dMY Squared Technology Group pays -- of its earnings as a dividend. Aetherium Acquisition pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios DMYY or GMFI?
dMY Squared Technology Group quarterly revenues are --, which are smaller than Aetherium Acquisition quarterly revenues of --. dMY Squared Technology Group's net income of -$4.6M is lower than Aetherium Acquisition's net income of $106.3K. Notably, dMY Squared Technology Group's price-to-earnings ratio is 59.33x while Aetherium Acquisition's PE ratio is 367.67x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for dMY Squared Technology Group is -- versus -- for Aetherium Acquisition. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DMYYdMY Squared Technology Group-- 59.33x -- -$4.6M GMFIAetherium Acquisition-- 367.67x -- $106.3K
-
Which has Higher Returns DMYY or GRAF?
Graf Global has a net margin of -- compared to dMY Squared Technology Group's net margin of --. dMY Squared Technology Group's return on equity of -- beat Graf Global's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital DMYYdMY Squared Technology Group-- -$1.16 -- GRAFGraf Global-- $0.08 -- -
What do Analysts Say About DMYY or GRAF?
dMY Squared Technology Group has a consensus price target of --, signalling downside risk potential of --. On the other hand Graf Global has an analysts' consensus of -- which suggests that it could fall by --. Given that dMY Squared Technology Group has higher upside potential than Graf Global, analysts believe dMY Squared Technology Group is more attractive than Graf Global.
Company Buy Ratings Hold Ratings Sell Ratings DMYYdMY Squared Technology Group0 0 0 GRAFGraf Global0 0 0 -
Is DMYY or GRAF More Risky?
dMY Squared Technology Group has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Graf Global has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock DMYY or GRAF?
dMY Squared Technology Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Graf Global offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. dMY Squared Technology Group pays -- of its earnings as a dividend. Graf Global pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios DMYY or GRAF?
dMY Squared Technology Group quarterly revenues are --, which are smaller than Graf Global quarterly revenues of --. dMY Squared Technology Group's net income of -$4.6M is lower than Graf Global's net income of $2.2M. Notably, dMY Squared Technology Group's price-to-earnings ratio is 59.33x while Graf Global's PE ratio is 39.46x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for dMY Squared Technology Group is -- versus -- for Graf Global. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DMYYdMY Squared Technology Group-- 59.33x -- -$4.6M GRAFGraf Global-- 39.46x -- $2.2M
-
Which has Higher Returns DMYY or LEGT?
Legato Merger Corp III has a net margin of -- compared to dMY Squared Technology Group's net margin of --. dMY Squared Technology Group's return on equity of -- beat Legato Merger Corp III's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital DMYYdMY Squared Technology Group-- -$1.16 -- LEGTLegato Merger Corp III-- $0.08 -- -
What do Analysts Say About DMYY or LEGT?
dMY Squared Technology Group has a consensus price target of --, signalling downside risk potential of --. On the other hand Legato Merger Corp III has an analysts' consensus of -- which suggests that it could fall by --. Given that dMY Squared Technology Group has higher upside potential than Legato Merger Corp III, analysts believe dMY Squared Technology Group is more attractive than Legato Merger Corp III.
Company Buy Ratings Hold Ratings Sell Ratings DMYYdMY Squared Technology Group0 0 0 LEGTLegato Merger Corp III0 0 0 -
Is DMYY or LEGT More Risky?
dMY Squared Technology Group has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Legato Merger Corp III has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock DMYY or LEGT?
dMY Squared Technology Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Legato Merger Corp III offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. dMY Squared Technology Group pays -- of its earnings as a dividend. Legato Merger Corp III pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios DMYY or LEGT?
dMY Squared Technology Group quarterly revenues are --, which are smaller than Legato Merger Corp III quarterly revenues of --. dMY Squared Technology Group's net income of -$4.6M is lower than Legato Merger Corp III's net income of $2.1M. Notably, dMY Squared Technology Group's price-to-earnings ratio is 59.33x while Legato Merger Corp III's PE ratio is 29.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for dMY Squared Technology Group is -- versus -- for Legato Merger Corp III. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DMYYdMY Squared Technology Group-- 59.33x -- -$4.6M LEGTLegato Merger Corp III-- 29.75x -- $2.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
How High Can SharkNinja Stock Go?
If you know popular consumer appliance brands Shark and Ninja,…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
61
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Alerts
Buy
78
SBET alert for Jul 16
SharpLink Gaming [SBET] is up 28.58% over the past day.
Buy
75
MP alert for Jul 16
MP Materials [MP] is up 0.48% over the past day.
Sell
38
NAIL alert for Jul 16
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 2.38% over the past day.
